Retinal structural changes in patients with Alzheimer's disease
DOI:
https://doi.org/10.31288/oftalmolzh201943337Keywords:
retina, Alzheimer's disease, RNFL, thickness, GCC, macular cubeAbstract
Background: Retinal disorders in patients with Alzheimer's disease (AD) are given special attention.
Purpose: To identify optical coherence tomography (OCT)-based retinal structural changes in patients with mild or moderate AD.
Materials and Methods: Forty-five AD patients (88 eyes; age, 66.2 ± 3.44 years) with mild or moderate cognitive impairments were involved into the study. All subjects underwent a conventional eye examination and OCT measurements. For Cirrus HD-OCT imaging, the Macular Cube 512 ? 128 Combo protocol was used. The RNFL, retinal ganglion cell layer (RGCL), and internal plexiform layer (IPL) thicknesses were determined using RNFL and ganglion cell complex (GCC) protocols.
Results: Compared with controls, patients with AD had 53.2% lower Mini Mental State Examination (MMSE) scores (p < 0.05). In addition, RNFL thicknesses in the temporal, superior and inferior quadrants in patients with AD were significantly (31.4%, 21.8% and 33.1%, respectively; p < 0.05) thinner compared to controls. Moreover, compared to controls, focal loss volume (FLV) and global loss volume (GLV) of GCC in AD patients were 1.7 times (p < 0.05) and 2.8 times (p < 0.01), respectively, increased, whereas central macular thickness, overall macular cube volume and average macular cube thickness were 14%, 17.8% and 3.5% decreased.
Conclusion: Our findings confirm the reports of changes in the retinal structure in patients with mild or moderate AD, particularly, the decreased GCC thickness and increased GCC FLV and GLV.
References
1.Alzheimer's Association. 2013 Alzheimer's disease facts and figures. Alzheimer's and Dementia. 2013;9(2):208-45.https://doi.org/10.1016/j.jalz.2013.02.003
2.Colligris P, Perez de Lara MJ, Colligris B, Pintor J. Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease. J Ophthalmol. 2018;2018: 8538573.https://doi.org/10.1155/2018/8538573
3.Alzheimer's Disease International World Alzheimer Report 2016: Improving healthcare for people living with dementia. London; 2016.
4.WHO. Dementia: a Public Health Priority. World Health Organization; 2012.
5.Trebbastoni A, D'Antonio F, Bruscolini A, Marcelli M, Cecere M, Campanelli A, et al. Retinal nerve ?bre layer thickness changes in Alzheimer's disease: results from a 12-month prospective case series. Neurosci Lett. 2016;629:165-70.https://doi.org/10.1016/j.neulet.2016.07.006
6.Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G. et al. Optical coherence tomography in Alzheimer's disease: a meta-analysis. PLoS One. 2015;10(8):e0134750.https://doi.org/10.1371/journal.pone.0134750
7.Armstrong RA. Alzheimer's Disease and the Eye. J Optom. 2009;2(3):101-58.https://doi.org/10.3921/joptom.2009.103
8.Wu Y, Wang X, Wang N, Han Y, Lu Y. Observation Study of the Retina with the Alzheimer's Disease or Amnestic Mild Cognitive Impairment Patients. J Clin Exp Ophthalmol. 2016;7(2):545.https://doi.org/10.4172/2155-9570.1000545
9.Lim JKH, Li Q-X, He Z, Vingrys AJ, Wong VHY, Currier N, Mullen J, Bui BV, Nguyen ChTO. The Eye As a Biomarker for Alzheimer's Disease. Front Neurosci. 2016;10:536-549.https://doi.org/10.3389/fnins.2016.00536
10.Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D. et al. The role of microglia in retinal neurodegeneration: Alzheimer's disease, Parkinson, and glaucoma. Front Aging Neurosci. 2017 Jul 6;9:214.https://doi.org/10.3389/fnagi.2017.00214
11.The World Medical Association (WMA) Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects Adopted by the General Assembly, Seoul, Korea, October 2008.https://doi.org/10.1515/9783110208856.233
12.Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A Practical Method for Grading the Cognitive State of Patients for the Clinician. J Psych Res. 1975; 12:189-98.https://doi.org/10.1016/0022-3956(75)90026-6
13.Mwanza JC, Durbin MK, Budenz DL, Sayyad FE, Chang RT, Neelakantan A, et al. Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology. 2012;119(6):1151-8.https://doi.org/10.1016/j.ophtha.2011.12.014
14.Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol. 2001;112:1860-1867.https://doi.org/10.1016/S1388-2457(01)00620-4
15.Iseri PK, Altinas T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 2006;26:18-24.https://doi.org/10.1097/01.wno.0000204645.56873.26
16.Berisha F, Feke GT, Trempe CL, Mcmeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007;48(5):2285-9.https://doi.org/10.1167/iovs.06-1029
17.Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D. Retinal nerve fiber layer abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography. Neurosci Lett. 2010. 9;480(1):69-72.https://doi.org/10.1016/j.neulet.2010.06.006
18.Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(9):5953-5958.https://doi.org/10.1167/iovs.13-12046
19.Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2015;45(1):45-56.https://doi.org/10.3233/JAD-141659
20.Choi SH, Park SJ, Kim NR. Macular Ganglion Cell-Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease. Plos One. 2016;11(9): e0162202.https://doi.org/10.1371/journal.pone.0162202
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Р. Н. Гулиева
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
